[1] PONIKOWSKI P, VOORS AA, ANKER SD, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC) Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur Heart J, 2016, 37(27):2129.
[2] TORRE-AMIONE G, ANKER SD, BOURGE RC, et al.Rwsults of a non-specific immunomodulation therapy in chronic heart failure(ACCLAIM trail):a placebo-controlled randomised trail[J].Lancet, 2016, 371(9608):228.
[3] WANG W, HU SS, KONG LZ, et al.Summary of Report on Cardiovascular Diseases in China, 2012[J].Biomed Environment Sci, 2014, 27(7):552.
[4] 王文, 朱曼璐, 王拥军.《中国心血管病报告2012》概要[J].中国循环杂志, 2013, 28(6):408.
[5] YANG Z, YU X, YU ML.Effects of shensongyangxin capsule on heart rate turbulence and heart rate variablity in chronic heart failure[J].Chin Med J(Engl), 2013, 126(22):4389.
[6] MAESTRI R, PINNA GD, ALLEGRINI P, et al.Linear and non-linear indices of heart rate variability in chronic heart failure mutual interrelationships and prognostic value[J].Comput Cardiol, 2016, 32:981.
[7] RAMIRE J, LAGUNA P, BAYES DE LUNA A, et al.QT/RR and T-peak-to-end/RR curvatures and slopes in chronic heart failure:Relation to sudden cardiac death[J].J Electrocardiol, 2014, 47(6):842.
[8] WU L, JIANG Z, LI C, et al.Prediction of heart rate variability on cardiac sudden death in heart failure patients:A systematic review[J].INT J CARDIOL, 2014, 174(3):875.
[9] TEIS MS, AREN R, ARCHIZA B, et al.Deep breathing heart rate variability is associated with Inspiratory muscle weakness in chronic heart failure[J].Physiother Res Int, 2013, 19(1):16.
[10] QUITTAN M, WIESINGER GF, CREVENNA R, et al.Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients[J].J Rehabil Med, 2001, 33(4):182.
[11] CAHALINL P, MATHER MA, SEMIGRAN MJ, et al.The six-minute walk test predicts peak oxygen up take and survival in patients with advanced heart failure[J].Chest, 1996, 110(2):325.
[12] 郭晓琳.心率变异性分析临床应用研究近况[J].心血管病防治知识(学术版), 2017, 16(7):143.
[13] 王昌生, 黎雄, 岳晓荷.心力衰竭病人血清NT-proBNP、mAlb水平与肾功能的相关性[J].中西医结合心脑血管病杂志, 2018, 16(18):2664.
[14] FLATT A, ESCO MR.Heart rate variability stabilization in athletes:towards more convenient data acquisition[J].Clin Physiol Funct Imag, 2016, 36(5):331.
[15] 杨美玲.心率变异性与心力衰竭患者房性心律失常发生的关系研究[J].现代诊断与治疗, 2014, 25(12):2818.
[16] 刘玉, 周利民, 张军.心率变异性对慢性心力衰竭病情评估及预后的应用价值[J].新疆医科大学学报, 2018, 41(3):291.
[17] 李克强, 胡嘉涛, 邹海平, 等.心率变异时域对老年慢性心力衰竭预后危险分层的定量研究[J].中国现代医药杂志, 2014, 16(6):8.
[18] 张辉, 冯婧, 梁婷, 等.心率和心率变异性与心力衰竭及预后的相关性[J].中国动脉硬化杂志, 2014, 3(17):274.
[19] 冷秀玉, 曾武涛, 陈国伟, 等.6分钟步行实验与慢性心力衰竭[J].中国心血管病杂志, 2003, 8(6):411.
[20] ROUL G, GEMAIN P, BARESIS P, et al.Does the 6-minute walk test predicts the prognosis in patients with NYHA class Ⅱ or Ⅲ chronic heart failure?[J].Am Heart J, 1998, 136(3):449.